Active, not recruitingNCT04381299

Will Autologous Platelet Rich Plasma Able To Restore Ovarian Function?

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
ART Fertility Clinics LLC
Principal Investigator
Laura Melado, PhD
ART Fertility Clinics LLC
Intervention
autologous platelet rich plasma(other)
Enrollment
35 target
Eligibility
18-40 years · FEMALE
Timeline
20212025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04381299 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials